Suppr超能文献

酮康唑及其脱酰基衍生物对恶性疟原虫和念珠菌分离株的活性。

Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolates.

作者信息

Pfaller M A, Segal J J, Krogstad D J

出版信息

Antimicrob Agents Chemother. 1982 Nov;22(5):917-9. doi: 10.1128/AAC.22.5.917.

Abstract

Deacylketoconazole was 15- to 50-fold more active against Plasmodium falciparum than was ketoconazole, based on [(3)H]hypoxanthine uptake and quantitative parasite counts. In contrast, there were no significant differences between these drugs in their activity against clinical isolates of Candida spp.

摘要

基于[³H]次黄嘌呤摄取和寄生虫定量计数,去酰基酮康唑对恶性疟原虫的活性比酮康唑高15至50倍。相比之下,这些药物对念珠菌临床分离株的活性没有显著差异。

相似文献

7
Ketoconazole resistance.
Lancet. 1982 Oct 2;2(8301):770-1.

本文引用的文献

2
Activity of imidazoles against Leishmania tropica in human macrophage cultures.
Am J Trop Med Hyg. 1981 May;30(3):566-9. doi: 10.4269/ajtmh.1981.30.566.
5
Human malaria parasites in continuous culture.持续培养中的人类疟原虫。
Science. 1976 Aug 20;193(4254):673-5. doi: 10.1126/science.781840.
7
Miconazole therapy for treatment of fungal infections in cancer patients.咪康唑治疗癌症患者真菌感染
Antimicrob Agents Chemother. 1979 Dec;16(6):792-7. doi: 10.1128/AAC.16.6.792.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验